KEZAR LIFE SCIENCES INC's ticker is KZR and the CUSIP is 49372L100. A total of 131 filers reported holding KEZAR LIFE SCIENCES INC in Q3 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,362 | -72.0% | 18,792 | -42.3% | 0.00% | – |
| Q2 2023 | $79,767 | +23.5% | 32,558 | +57.8% | 0.00% | – |
| Q1 2023 | $64,581 | -55.5% | 20,633 | 0.0% | 0.00% | – |
| Q4 2022 | $145,256 | -9.3% | 20,633 | +11.0% | 0.00% | – |
| Q3 2022 | $160,086 | -0.5% | 18,593 | -4.4% | 0.00% | – |
| Q2 2022 | $160,860 | -33.6% | 19,451 | +33.4% | 0.00% | – |
| Q1 2022 | $242,253 | -15.0% | 14,576 | -14.6% | 0.00% | – |
| Q4 2021 | $285,000 | +129.8% | 17,058 | +18.8% | 0.00% | – |
| Q3 2021 | $124,000 | -1.6% | 14,363 | -32.1% | 0.00% | – |
| Q1 2021 | $126,000 | +3.3% | 21,139 | -9.5% | 0.00% | – |
| Q4 2020 | $122,000 | +38.6% | 23,356 | +28.9% | 0.00% | – |
| Q3 2020 | $88,000 | -6.4% | 18,114 | +5.6% | 0.00% | – |
| Q2 2020 | $94,000 | +59.3% | 17,158 | +26.8% | 0.00% | – |
| Q1 2020 | $59,000 | – | 13,534 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 320,000 | $1,283,000 | 0.56% |
| CHI Advisors LLC | 154,255 | $619,000 | 0.47% |
| Logos Global Management LP | 122,931 | $493,000 | 0.12% |
| Bellevue Group AG | 1,550,669 | $6,218,000 | 0.10% |
| Alambic Investment Management, L.P. | 26,920 | $108,000 | 0.09% |
| PA Capital LLC | 19,758 | $79,000 | 0.07% |
| FRAZIER MANAGEMENT LLC | 90,578 | $363,000 | 0.06% |
| MYDA Advisors LLC | 27,505 | $110,000 | 0.05% |
| BVF INC/IL | 116,712 | $468,000 | 0.04% |
| RBF Capital, LLC | 89,450 | $359,000 | 0.03% |